FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 4 mg/1 mL; .3 mg/1 mL; 40 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 4 mg/1 mL; .3 mg/1 mL; 40 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Papaverine Hydrochloride | 3 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Papaverine Hydrochloride | 3 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| OSRX, Inc. | 117108300 | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9065 | 83826-9065-0 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9076 | 83826-9076-5 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | .1 mg/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9006 | 83826-9006-5 | Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9066 | 83826-9066-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9059 | 83826-9059-2 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9012 | 83826-9012-3 | Atropine Sulfate | .5 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9010 | 83826-9010-3 | Atropine Sulfate | .1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9011 | 83826-9011-3 | Atropine Sulfate | .25 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9080 | 83826-9080-1 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 75 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 5 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OSRX, Inc. | 117108300 | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OurPharma LLC | 041422637 | 73013-4001 | 73013-4001-2 | Ropivacaine Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OurPharma LLC | 041422637 | 73013-4002 | 73013-4002-2 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| OurPharma LLC | 041422637 | 73013-1028 | 73013-1028-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2025-2 | valid | 2026-08-10 | |
| OurPharma LLC | 041422637 | 73013-1029 | 73013-1029-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1 mg/1 mL; 2 ug/1 mL | 2025-2 | valid | 2026-08-10 |